PCLOF (PharmaCielo) Ending Cash Position: $0.21 Mil (As of Dec. 2025)


What is PharmaCielo Ending Cash Position?

PharmaCielo PCLOF +3.23% Ending Cash Position is $0.21 Mil as of Dec. 2025. The stock has 5 warning signs investors should review.

PharmaCielo's Ending Cash Position for the quarter that ended in Dec. 2025 was $0.21 Mil.

PharmaCielo's quarterly Ending Cash Position increased from Jun. 2025 ($0.01 Mil) to Sep. 2025 ($0.19 Mil) and increased from Sep. 2025 ($0.19 Mil) to Dec. 2025 ($0.21 Mil).

PharmaCielo's annual Ending Cash Position declined from Dec. 2021 ($4.17 Mil) to Dec. 2022 ($0.13 Mil) and declined from Dec. 2022 ($0.13 Mil) to Dec. 2023 ($0.05 Mil).

PharmaCielo Ending Cash Position Related Terms

PharmaCielo Ending Cash Position Historical Data

* Premium members only.

The historical data trend for PharmaCielo's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaCielo Ending Cash Position Chart

PharmaCielo Annual Data
Trend Aug17 Aug18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial 10.38 6.92 4.17 0.13 0.05

PharmaCielo Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.10 0.01 0.19 0.21

PharmaCielo Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

PharmaCielo's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.129+-0.083
=0.05

PharmaCielo's Ending Cash Position for the quarter that ended in Dec. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.185+0.024
=0.21

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $0.21 Mil mean?
PharmaCielo (PCLOF) has a Ending Cash Position of $0.21 Mil as of Dec. 2025. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on PharmaCielo and its competitors.
Is PharmaCielo's Ending Cash Position too high?
PharmaCielo's current Ending Cash Position is $0.21 Mil.
How does PharmaCielo's Ending Cash Position compare to ZTS and UTHR?
PharmaCielo's Ending Cash Position of $0.21 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Drug Manufacturers company?
A good Ending Cash Position depends on the Drug Manufacturers industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on PharmaCielo and its competitors. PharmaCielo's current Ending Cash Position is $0.21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaCielo stock overvalued right now?
Based on GuruFocus' analysis, PharmaCielo (PCLOF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.11, compared to a current price of $0.05 — trading 55% below its estimated fair value. The current Ending Cash Position is $0.21 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For PharmaCielo (PCLOF), the current Ending Cash Position is $0.21 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PharmaCielo Business Description

Other Exchanges PCLO:Canada
Address 82 Richmond Street East, Suite 805, Toronto, ON, CAN, M5C 1P1
PharmaCielo Ltd is a pharma company, with a focus on ethical and sustainable processing and supplying of both THC(tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. It is licensed to produce both CBD-dominant and THC-dominant cannabis extracts. The company operates in Canada, Colombia, Italy, and Mexico and generates the majority of its revenue in the form of the Sale of Cannabis derivative products in America followed by Australia, Africa and Europe.